Trial Profile
Efficacy of inhaled rhDNase for acute asthma in childhood.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2011
Price :
$35
*
At a glance
- Drugs Dornase alfa (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 14 May 2009 Trial sponsor (Roche), lead trial centre (Roche Nederland), investigator (Boogaard R) added as reported by ISRCTN: Current Controlled Trials.
- 27 Dec 2008 New trial record.